Collectively, our results confirm ERRα as a master regulator of oncometabolic and proliferating signals in breast cancer, and provide insights into the molecular mechanisms underpinning VDR genomic and antitumor action in advanced breast cancer. Here, VDR is linked to breast carcinoma.